Eplerenone in the Management of Abdominal Aortic Aneurysms
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 172 participants.
Also called NCT02345590
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 172 participants
- Registry
-
NCT02345590
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia
- Registry status
- Unknown status
Technical summary
Registry record NCT02345590. Randomized; quadruple masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Eplerenone in the Management of Abdominal Aortic Aneurysms
- Condition
- Aortic Aneurysm, Abdominal
- Intervention (Drug)
- Eplerenone
- Lead sponsor
- Bayside Health
- Collaborator
- Baker Heart and Diabetes Institute
Record details
- Record id
cardio:ct-nct02345590- Content hash
d083f9837a01f0a9a4fa8406a297dece5d31f966431125e66fa17267e501e8ed